← FDA DRUG APPROVALS
FDA ANDA · ANDA214836
GOOD SENSE DUAL ACTION BACK PAIN
acetaminophen, ibuprofen
Sponsor: L PERRIGO CO
APPLICATION
ANDA214836
TYPE
ANDA
ORIGINAL APPROVAL
2023-02-28
LATEST ACTION
2025-10-22
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
ACETAMINOPHEN AND IBUPROFENOver-the-counter
ACETAMINOPHEN 250MG, IBUPROFEN 125MG · TABLET · ORAL
Approval history
2025-10-22Labeling · Supplement 2 · standardAP
2025-10-22Labeling · Supplement 5 · standardAP
2025-10-22Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.